Elective orthopedic surgery, a model for the study of cytokine activation and regulation

Cytokine

Volumn 10, Issue 11, 1998, Pages 897-903

  Van Deuren, Marcel ^a   Twickler, Th B ^b   De Waal Malefyt, M C ^b   Van Beem, H ^b   Van Der Ven Jongekrijg, J ^b   Verschueren, C M M ^b   Van Der Meer, J W M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD CELL; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTIVE SURGERY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MALE; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; TOTAL HIP PROSTHESIS;

EID: 0032421099     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0367     Document Type: Article

References (51)

1. 1. Van Deuren M, Van der Ven-Jongekrijg J, Bartelink AKM, Van Dalen R, Sauerwein RW, Van der Meer JWM (1995) Correlation between proinflammatory cytokines and antiinflamatory mediators and the severity of disease in meningococcal infections. J Infect Dis 172:433-439.
2. 2. Roumen RM, Hendriks T, Van der Ven-Jongekrijg J, Nieuwenhuizen GA, Sauerwein RW, Van der Meer JWM, Goris RJ (1993) Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory disetress syndrome and multiple organ failure. Ann Surg 218:769-776.
3. 3. Cruickshank AM, Fraser WD, Burns HJ, Van Damme J, Shenkin A (1990) Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci Colch 79:161-165.
4. 4. Lahat N, Zlotnick AY, Shtiller R, Bar I, Merin G (1992) Serum levels of IL-1, IL-6 and tumor necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 89:255-260.
5. 5. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ (1992) Systemic cytokine response after major surgery. Br J Surg 79:757-760.
6. 6. Parry-Billings M, Baigrie RJ, Lamont PM, Morris PJ, Newsholme EA (1992) Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg 127:1237-1240.
7. 7. Matsuura N, Murata A, Toda H, Uda K, Nakagawa H, Tomita N, Ishida H, Morikawa Y, Kakudo K (1993) Serial changes in serum interleukin-1 receptor antagonist (IL-1ra), interleukin-6, interleukin-8 after major elective surgeries (Abstract). Lymphokine Cytokine Res 12:392.
8. 8. Chikanza IC, Roux-Lombard P, Dayer J-M, Panayi GS (1993) Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis. Clin Exp Immunol 92:19-22.
9. 9. Shenkin A (1994) Cytokine changes in the postoperative period. Proc Nutr Soc 53:159-167.
10. 10. Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, Hisano S, Ogawa M (1994) Elevation of circulating interleukin 6 after surgery: Factors influencing the serum level. Cytokine 6:181-186.
11. 11. O'Nualláin EM, Puri P, Mealy K, Reen DJ (1995) Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. Clin Immun Immunopath 76:96-101.
12. 12. Kristiansson M, Soop M, Saraste L, Sundqvist KG, Suontaka AM, Blombäck M (1995) Cytokine and coagulation characteristics of retrieved blood after arthroplasty. Intensive Care Med 21:989-995.
13. 13. Luger A, Graf H, Schwarz H-P, Stummvoll H-K, Luger TA (1986) Decreased serum interleukin-1 activity and monocyte interleukin-1 production in patients with fatal sepsis. Crit Care Med 14:458-461.
14. 14. Helminen M, Vesikari T (1990) Interleukin-1 production in bacterial meningitis. Scand J Infect Dis 22:105-108.
15. 15. Helminen M (1991) Interleukin-1 production from peripheral blood monocytes in septic infections in children. Scand J Infect Dis 23:607-611.
16. 16. Simpson SQ, Modi HN, Balk RA, Bone RC, Casey LC (1991) Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med 19:1060-1091.
17. 17. Munoz C, Carlet J, Fitting C, Misset B, Blériot J-P, Cavaillon J-M (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754.
18. 18. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL (1993) Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with sepsis syndrome. J Clin Invest 91:853-861.
19. 19. Platzer C, Döcke W-D, Volk HD (1993) Fatal outcome of septic disease is associated with lack of TNF-alpha expression in PBMC (Abstract). Lymphokine Cytokine Res 12:399.
20. 20. Van Deuren M, Van der Ven-Jongekrijg J, Demacker PNM, Bartelink AKM, Van Dalen R, Sauerwein RW, Gallati H, Vannice JL, Van der Meer JWM (1994) Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 169:157-161.
21. 21. Keuter M, Dharmana E, Gasem MH, Van der Ven-Jongekrijg J, Djokomoeljanto R, Dolmans WMV, Demacker P, Sauerwein R, Gallati H, Van der Meer JWM (1994) Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 169:1306-1311.
22. 22. Setrakian JC, Yee J, Christou NV (1994) Reduced tumor necrosis factor α production in lipopolysaccharide-treated whole blood from patients in the intensive care unit. Arch Surg 129:187-192.
23. 23. Ertel W, Kremer J-P, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347.
24. 24. Ziegler-Heitbrock HWL (1995) Molecular mechanism in tolerance to lipopolysaccharide. J Inflammation 45:13-26.
25. 25. Drenth JPH, Van Uum SHM, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JWM (1995) Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production. J Appl Physiol 79:1497-1503.
26. 26. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236-241.
27. 27. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel T (1996) Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. JACC 28:964-971.
28. 28. Latini R, Bianchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, Maggioni AP, Mengozzi M, Romano S, Shapiro L, Sironi M, Tognoni G, Turato R, Ghezzi P (1994) Cytokines in acute myocardial infarction: Selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol 23:1-6.
29. 29. Neumann F-J, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schömig A (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92:748-755.
30. 30. Basha MA, Meyer S, Kunkel SL, Strieter RM, Rivers EP, Popovich J (1991) Presence of tumor necrosis factor in humans undergoing cardiopulmonary resuscitation with return of spontaneous circulation. J Crit Care 6:185-189.
31. 31. Cannon JG, Friedberg JS, Gelfand JA, Tompkins RG, Burke JF, Dinarello CA (1992) Circulating interleukin-1β and tumor necrosis factor-α concentrations after burn injury in humans. Crit Care Med 20:1414-1419.
32. 32. Hoch RC, Rodriguez R, Manning T, Bishop M, Mead P, Shoemaker WC, Abraham E (1993) Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 21:839-845.
33. 33. Fong Y, Moldawer LL, Marano M, Wei HE, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF (1989) Endotoxemia elicits increased circulating β2-IFN/IL-6 in man. J Immunol 142:2321-2324.
34. 34. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA (1991) Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338:1423-1424.
35. 2 activity by intraveneous infusion of endotoxin in patients with neoplasia. J Immunother 12:242-246.
36. 36. Granowitz EV, Porat R, Mier JW, Orencole SF, Kaplanski G, Lynch EA, Ye K, Vannier E, Wolff SM, Dinarello CA (1993) Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 151:1637-1634.
37. 37. Kimmings AN, Pajkrt D, Zaaijer K, Moojen TM, Meenan JK, Ten Cate JW, Van Deventer SJH (1996) Factors involved in early in vitro endotoxin hyporesponsiveness in human endotoxemia. J Endotoxin Res 3:283-289.
38. 38. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R (1995) Slowing of wound healing by psychological stress. Lancet 346:1194-1196.
39. 39. Keel M, Schregenberger N, Steckholzer U, Ungethum U, Kenney J, Trentz O, Ertel W (1996) Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma 41:430-437.
40. 40. Cabie A, Fitting C, Farkas JC, Laurian C, Cormier JM, Carlet J, Cavaillon JM (1992) Influence of surgery on in vitro cytokine production by human monocytes. Cytokine 4:576-580.
41. 41. Sonnenfeld G, Davis S, Taylor GR, Mandel AD, Konstantinova IV, Lesnyak A, Fuchs BB, Peres C, Tkackzuk J, Schmitt DA (1996) Effect of space flight on cytokine production and other immunologic parameters of rhesus monkeys. J Interferon Cytokine Res 16:409-415.
42. 42. Mengozzi M, Ghezzi P (1993) Cytokine down-regulation in endotoxin tolerance. Eur Cyt Netw 4:89-98.
43. 43. Lundy J, Ford CM (1983) Surgery, trauma and immune suppression. Evolving the mechanism. Ann Surg 197:434-438.
44. 44. Lennard TW, Shenton BK, Borzotta A, Donelly PK, White M, Gerrie LM, Proud G, Taylor RM (1985) The influence of surgical operations on components of the human immune system. Br J Surg 72:771-776.
45. 45. Baxevanis CN, Papilas K, Dedoussis GVZ, Pavlis T, Papamichail M (1994) Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery. Clin Immunol Immunopathol 71:82-88.
46. 46. Zellweger R, Zhu X-H, Wichman MW, Ayala A, DeMaso CM, Chaudry IH (1996) Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol 157:5748-5754.
47. 47. Van Deuren M, Netea MG, Hijmans A, Demacker PNM, Neeleman C, Sauerwein RW, Bartelink AKM, Van der Meer JWM (1998) Post-transcriptional down-regulation of tumor necrosis factor-α and interleukin-1β production in acute meningococcal Infections. J Infect Dis 177:1401-1405.
48. 48. Van Deuren M, Van der Ven-Jongekrijg J, Keuter M, Demacker PNM, Van der Meer JWM (1993) Cytokine production in whole blood cultures. J Int Fed Clin Chem 5:216-219.
49. 49. Barrera P, Boerbooms AMTh, Janssen EM, Sauerwein RW, Gallati H, Mulder J, De Boo Th, Demacker PNM, Van de Putte LBA, Van der Meer JWM (1993) Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 36:1070-1079.
50. 50. Van Deuren M, Van der Ven-Jongekrijg J, Vannier E, Van Dalen R, Pesman G, Bartelink AKM, Dinarello CA, Van der Meer JWM (1997) The pattern of interleukin-1β (IL-1β) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 90: 1101-1108.
51. 51. Netea M, Drenth JPH, De Bont N, Hijmans A, Keuter M, Dharmana E, Demacker PNM, Van der Meer JWM (1996) A semi-quantitative reverse transcriptase polymerase chain reaction method for measurement of mRNA for TNFα and IL-1β in whole blood cultures: its application in typhoid fever and exentric exercise. Cytokine 8:739-744.